🇺🇸 Glargine and Lispro insulin in United States

Glargine and Lispro insulin (Glargine and Lispro insulin) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Glargine and Lispro insulin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Glargine and Lispro insulin approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Glargine and Lispro insulin in United States?

Universidad de Guanajuato is the originator. The local marketing authorisation holder may differ — check the official source linked above.